Jennifer Freedman

Affiliations: 
Duke University, Durham, NC 
Google:
"Jennifer Freedman"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Mukherjee D, Previs RA, Haines C, et al. (2023) Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis. Cancer Research
Zhang S, Mao M, Lv Y, et al. (2022) A widespread length-dependent splicing dysregulation in cancer. Science Advances. 8: eabn9232
Odera JO, Abo MA, Patierno SR, et al. (2022) Changing the landscape of non-small cell lung cancer disparities. Journal of Cancer Biology. 2: 33-38
Al Abo M, Gearhart-Serna L, Van Laere S, et al. (2022) Adaptive stress response genes associated with breast cancer subtypes and survival outcomes reveal race-related differences. Npj Breast Cancer. 8: 73
Patierno BM, Foo WC, Allen T, et al. (2021) Characterization of a castrate-resistant prostate cancer xenograft derived from a patient of West African ancestry. Prostate Cancer and Prostatic Diseases
George DJ, Halabi S, Heath EI, et al. (2021) A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer. Cancer
Al Abo M, Hyslop T, Qin X, et al. (2021) Differential alternative RNA splicing and transcription events between tumors from African American and white patients in The Cancer Genome Atlas. Genomics
Freedman JA, Al Abo M, Allen TA, et al. (2021) Biological Aspects of Cancer Health Disparities. Annual Review of Medicine. 72: 229-241
Williams KP, Barrett NJ, Oldham CE, et al. (2020) Abstract IA18: North Carolina Central University and Duke Cancer Institute's collaborative cancer research and education program: Connecting cancer disparities translational research, clinical trials operations, and community engagement Cancer Epidemiology, Biomarkers & Prevention
Robinson TJ, Freedman JA, Al Abo M, et al. (2019) Alternative RNA Splicing as a Potential Major Source of Untapped Molecular Targets in Precision Oncology and Cancer Disparities. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
See more...